CIK 0001746466 · Non-accelerated filer<br>Smaller reporting company
Equillium, Inc.
Sign in to watch- Ticker
- EQ
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 821554746
- Phone
- (858) 412-5302
- Business address
- 2223 AVENIDA DE LA PLAYA, SUITE 105, LA JOLLA, CA, 92037
- 4 Open-market sale Chief Scientific Officer sold 25,000 shares at $5.62 ($140,395)
- 8-K Event Executive or director change
- 8-K Event Material agreement · Other events
- 424B5 Offering Prospectus
- 424B5 Offering Prospectus
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Regulation FD disclosure · Other events
- 4 Open-market sale Chief Scientific Officer sold 250,000 shares at $8.13 ($2,033,475)
- 8-K Event Material agreement
- 424B5 Offering Prospectus
- 8-K Event Other events
- 4 Other acquisition Chief Financial Officer acquired 5,014 shares (other)
- 4 Other acquisition Sr. Vice President and COO acquired 9,570 shares (other)
- 8-K Event Executive or director change
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 18 of 24 · 469 filings